Martinez, B. K., Bunz, T. J., Eriksson, D., Meinecke, A., Sood, N. A., & Coleman, C. I. (2018). Effectiveness and safety of rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation and heart failure. ESC Heart Fail.
Style de citation ChicagoMartinez, Brandon K., Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, Nitesh A. Sood, et Craig I. Coleman. "Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients With Non‐valvular Atrial Fibrillation and Heart Failure." ESC Heart Fail 2018.
Style de citation MLAMartinez, Brandon K., et al. "Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients With Non‐valvular Atrial Fibrillation and Heart Failure." ESC Heart Fail 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.